[1]
AHA. Heart Disease and Stroke Statistics - Update. 2005.
[2]
Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375(9718): 895-905.
[3]
Nagai M, Dote K, Kato M, et al. Visit-to-visit blood pressure variability and classes of antihypertensive agents; associations with artery remodeling and the risk of stroke. Curr Pharm Des 2016; 22(3): 383-9.
[4]
Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis. Lancet 2010; 375(9718): 906-15.
[5]
Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220(1): 155-9.
[6]
Diaz KM, Veerabhadrappa P, Kashem MA, et al. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res 2012; 35(1): 55-61.
[7]
Schillaci G, Bilo G, Pucci G, et al. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012; 60(2): 369-77.
[8]
Omboni S, Posokhov IN, Rogoza AN. Relationships between 24-h blood pressure variability and 24-h central arterial pressure, pulse wave velocity and augmentation index in hypertensive patients. Hypertens Res 2017; 40(4): 385-91.
[9]
Zhou TL, Henry RMA, Stehouwer CDA, van Sloten TT, Reesink KD, Kroon AA. Blood pressure variability, arterial stiffness, and arterial remodeling. Hypertension 2018; 72(4): 1002-10.
[10]
Shimbo D, Shea S, McClelland RL, et al. Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens 2013; 26(7): 896-902.
[11]
Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5(3): 184-92.
[12]
Okada R, Okada A, Okada T, Nanasato M, Wakai K. Visit-to-visit blood pressure variability is a marker of cardiac diastolic function and carotid atherosclerosis. BMC Cardiovasc Disord 2014; 14: 188.
[13]
Nagai M, Dote K, Kato M, et al. Visit-to-visit BP variability, average BP level and carotid arterial stiffness in the elderly: Results from a prospective study. J Hum Hypertens 2017; 31: 292-8.
[14]
Tedla YG, Yano Y, Carnethon M, Greenland P. Association between long-term blood pressure variability and 10-year progression in arterial stiffness: The Multiethnic Study of Atherosclerosis. Hypertension 2017; 69(1): 118-27.
[15]
Song H, Wei F, Liu Z, et al. Visit-to-visit variability in systolic blood pressure: correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients. Clin Exp Hypertens 2015; 37(1): 63-9.
[16]
Nagai M, Dote K, Kato M, Sasaki S, Oda N. Visit-to-visit blood pressure variability: An epiphenomenon or a risk for the progression of carotid artery remodelling? Eur Heart J Cardiovasc Pharmacother 2017; 3(2): 90.
[17]
Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is a novel risk factor for the progression of coronary artery calcification. Hypertens Res 2013; 36(11): 996-9.
[18]
Kim JS, Park S, Yan P, Jeffers BW, Cerezo C. Effect of inter-individual blood pressure variability on the progression of atherosclerosis in carotid and coronary arteries: A post hoc analysis of the NORMALISE and PREVENT studies. Eur Heart J Cardiovasc Pharmacother 2017; 3(2): 82-9.
[19]
Aoyama R, Takano H, Suzuki K, et al. The impact of blood pressure variability on coronary plaque vulnerability in stable angina: An analysis using optical coherence tomography. Coron Artery Dis 2017; 28(3): 225-31.
[20]
Kawai T, Ohishi M, Ito N, et al. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease. J Hypertens 2013; 31(7): 1387-95.
[21]
Lau KK, Wong YK, Chan YH, et al. Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases--relationships and comparisons with vascular markers of atherosclerosis. Atherosclerosis 2014; 235(1): 230-5.
[22]
Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012; 126(5): 569-78.
[23]
Crouse JR, Goldbourt U, Evans G, et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1996; 27(1): 69-75.
[24]
Whisnant JP, Homer D, Ingall TJ, Baker HL Jr, O’Fallon WM, Wievers DO. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 1990; 21(5): 707-14.
[25]
Szirmai IG, Kamondi A, Magyar H, Juhász C. Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke 1993; 24(12): 1811-6.
[26]
Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 2000; 102(13): 1536-41.
[27]
Lorenz MW, Polak JF, Kavousi M, et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): A meta-analysis of individual participant data. Lancet 2012; 379(9831): 2053-62.
[28]
van Sloten TT, Schram MT, van den Hurk K, et al. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol 2014; 63(17): 1739-47.
[29]
Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37(5): 1236-41.
[30]
van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32(2): 454-60.
[31]
Pringle E, Phillips C, Thijs L, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21(12): 2251-7.
[32]
Wang JG, Yan P, Jeffers BW. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials. J Am Soc Hypertens 2014; 8(5): 340-9.
[33]
Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: A meta-analysis of randomized controlled trials. Stroke 2006; 37(7): 1933-40.
[34]
Higashihara T, Nagai M, Dote K, et al. Exaggerated coronary intimal thickening: An optical coherence tomography finding in myocardial bridge with concomitant spasm. Coron Artery Dis 2019; 30: 234-6.
[35]
Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients. J Hum Hypertens 2006; 20(10): 787-94.
[36]
Rothwell PM. Limitations of the usual blood pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-48.
[37]
Shi R, Liu K, Shi D, Liu Q, Chen X. Effects of amlodipine and valsartan on blood pressure variability and pulse wave velocity in hypertensive patients. Am J Med Sci 2017; 353(1): 6-11.
[38]
Matsui Y, O’Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012; 59(6): 1132-8.
[39]
Rakugi H, Ogihara T, Saruta T, et al. Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. J Hypertens 2015; 33(10): 2165-72.
[40]
Sato N, Saijo Y, Sasagawa Y, et al. Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis. Clin Exp Hypertens 2015; 37(5): 411-9.
[41]
Kingwell BA, Cameron JD, Gillies KJ, Jennings GL, Dart AM. Arterial complflex function in athletes and hypertensives. Am J Physiol 1995; 268(1 Pt 2): H411-8.
[42]
Watson RD, Stallard TJ, Flinn RM, Littler WA. Factors determining direct arterial pressure and its variability in hypertensive man. Hypertension 1980; 2(3): 333-41.
[43]
O’Rourke MF. Basic concepts for the understanding of large arteries in hypertension. J Cardiovasc Pharmacol 1985; 7(Suppl. 2): S14-21.
49
11